Current developments in lipid-lowering treatments

被引：0
|
作者：
Krempf, M [1 ]
机构：
[1] Hop Hotel Dieu, Clin Endocrinol Malad Metab & Nutr, Nantes, France
来源：
ANNALES D ENDOCRINOLOGIE | 2005年 / 66卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：39 / 40
页数：2
相关论文
共 50 条
  • [1] LIPID-LOWERING TREATMENTS
    DAIROU, F
    PRESSE MEDICALE, 1987, 16 (26): : 1277 - 1281
  • [2] COST IMPLICATIONS OF LIPID-LOWERING TREATMENTS
    RECKLESS, JPD
    PHARMACOECONOMICS, 1994, 6 (04) : 310 - 322
  • [3] Influence of lipid-lowering treatments on homocyteinemia
    Thomas, C
    REVUE DE MEDECINE INTERNE, 2003, 24 (05): : 334 - 335
  • [4] Prediction of response to lipid-lowering treatments
    Tomlinson, Brian
    Chan, Paul
    Liu, Zhong-Min
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2018, 3 (06): : 335 - 337
  • [5] Current developments in lipid-lowering therapy for the patient with chronic kidney disease
    Burnhope, Emma
    Green, Darren
    Kalra, Philip A.
    Kalra, Paul R.
    CLINICAL LIPIDOLOGY, 2011, 6 (06) : 693 - 702
  • [6] EFFECTS OF VARIOUS LIPID-LOWERING TREATMENTS IN DIABETICS
    STEINER, G
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 : S35 - S39
  • [7] Statin intolerance and new lipid-lowering treatments
    Mesi, Oltion
    Lin, Charlie
    Ahmed, Haitham
    Cho, Leslie S.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2021, 88 (07) : 381 - 387
  • [8] COST IMPLICATIONS OF LIPID-LOWERING TREATMENTS - DISCUSSION
    HITCHINGS, C
    RECKLESS, JPD
    ROGERS, D
    HILLMAN, A
    PHARMACOECONOMICS, 1994, 6 (04) : 322 - 323
  • [9] Influence of lipid-lowering treatments on homocyteinemia - Reply
    Roblin, X
    Phelip, JM
    Heluwaert, F
    REVUE DE MEDECINE INTERNE, 2003, 24 (05): : 335 - 335
  • [10] Current issues of lipid-lowering and antithrombotic therapy
    Valentin Fuster
    Current Cardiology Reports, 1999, 1 (3) : 173 - 174
12345